Ron Cohen

2021

In 2021, Ron Cohen earned a total compensation of $1.6M as President and Chief Executive Officer at Acorda Therapeutics, a 9% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$459,499
Option Awards$252,672
Salary$743,123
Stock Awards$182,410
Other$8,700
Total$1,646,404

Cohen received $743.1K in salary, accounting for 45% of the total pay in 2021.

Cohen also received $459.5K in non-equity incentive plan, $252.7K in option awards, $182.4K in stock awards and $8.7K in other compensation.

Rankings

In 2021, Ron Cohen's compensation ranked 6,848th out of 12,415 executives tracked by ExecPay. In other words, Cohen earned more than 44.8% of executives.

ClassificationRankingPercentile
All
6,848
out of 12,415
45th
Division
Manufacturing
2,983
out of 5,505
46th
Major group
Chemicals And Allied Products
1,322
out of 2,375
44th
Industry group
Drugs
1,178
out of 2,096
44th
Industry
Biological Products, Except Diagnostic Substances
280
out of 449
38th

Pay ratio

Ron Cohen's Pay$1,646,404
Median Employee's Pay$226,642
Pay Ratio

7

to 1

In 2021, the annual total compensation of Ron Cohen was $1,646,404.

The annual total compensation of the median employee at Acorda Therapeutics was $226,642.

The ratio of Ron Cohen's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 28, 2022.

Cohen's colleagues

We found four more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2021.

2021

Burkhard Blank

Acorda Therapeutics

Chief Medical Officer

2021

Lauren Sabella

Acorda Therapeutics

Chief Operating Officer

2021

Kerry Clem

Acorda Therapeutics

Chief Commercial Officer

2021

Michael Gesser

Acorda Therapeutics

Chief Finance Officer and Treasurer

News

You may also like